Prothionamide
 | |
 | |
| Systematic (IUPAC) name | |
|---|---|
| 2-propylpyridine-4-carbothioamide | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Identifiers | |
14222-60-7  | |
| J04AD01 | |
| PubChem | CID 666418 |
| ChemSpider |
579891  |
| UNII |
76YOO33643 |
| Chemical data | |
| Formula | C9H12N2S |
| 180.271 g/mol | |
|
SMILES
| |
| |
| (what is this?) (verify) | |
Protionamide (or prothionamide) is a drug used in the treatment of tuberculosis.[1]
It has also been tested for use in the treatment of leprosy.[2]
See also
References
- ↑ Wang F, Langley R, Gulten G et al. (January 2007). "Mechanism of thioamide drug action against tuberculosis and leprosy". J. Exp. Med. 204 (1): 73–8. doi:10.1084/jem.20062100. PMC 2118422. PMID 17227913.
- ↑ Fajardo TT, Guinto RS, Cellona RV, Abalos RM, Dela Cruz EC, Gelber RH (March 2006). "A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy". Am. J. Trop. Med. Hyg. 74 (3): 457–61. PMID 16525107.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||